APPSC Group-I Prelims 2024 — Paper-II (General Aptitude) · Q 66
Identify India's first indigenously developed CAR-T cell therapy for which Central Drugs Standard Control Organization (CDSCO) granted market approval :
- (a) NexCAR19
- (b) IND YESCARTA
- (c) TECARTUS
- (d) BREYANZI-BH
Official APPSC answer: (a)
Solution: The answer is (A): NexCAR19 is India's first indigenously developed CAR-T cell therapy, and CDSCO granted it market approval in October 2023. Option-by-option analysis • ✅ (A) — NexCAR19 is India's first indigenously developed CAR-T cell therapy. It was developed by ImmunoACT, a startup incubated at IIT Bombay, with Tata Memorial Centre, Mumbai. It targets the CD19 protein on B cells. CDSCO granted it market approval in October 2023 for relapsed or refractory B-cell lymphoma and B-cell acute lymphoblastic leukaemia. Hence it is the keyed answer. • ❌ (B) — IND YESCARTA is linked to Yescarta, whose generic name is axicabtagene ciloleucel. Yescarta was developed by Kite Pharma, now part of Gilead. It is a foreign-origin CAR-T therapy, not India's first indigenous CAR-T. So it cannot be the answer. • ❌ (C) — TECARTUS is brexucabtagene autoleucel, again developed by Kite Pharma/Gilead. It…
APPSC Group-I Prelims 2022 — Paper-II (General Aptitude) · Q 85
In India 3D-Printed Cornea and 3D-Printed Liver Tissue were developed respectively by
- (a) AIIMS New Delhi and Next Big Innovation Labs
- (b) IIT Hyderabad and Next Big Innovation Labs
- (c) CCMB Hyderabad and Pandorum Technologies
- (d) L.V. Prasad Eye Institute and Pandorum Technologies
Official APPSC answer: (d)
Solution: The answer is (D): the cornea was led by L.V. Prasad Eye Institute, and the liver tissue was developed by Pandorum Technologies. Option-by-option analysis • ❌ (A) — AIIMS New Delhi is a premier medical institute, but it did not develop India's first 3D-printed cornea. Next Big Innovation Labs is a Bengaluru 3D-bioprinting startup known for skin tissue work, not for India's 3D-printed liver tissue. So the pair is wrong. • ❌ (B) — IIT Hyderabad was a collaborator in the cornea project led by L.V. Prasad Eye Institute, not the lead developer. Next Big Innovation Labs is not credited with the 3D-printed liver tissue. Hence the pair fails. • ❌ (C) — CCMB Hyderabad was also a collaborator in the cornea project, not the lead. Pandorum Technologies is indeed the developer of 3D-printed liver tissue, so this option is only half right. A half-right pair is not the answer. • ✅ (D) — L.V. Prasad…
APPSC Group-I Prelims 2022 — Paper-II (General Aptitude) · Q 89
A fermentation process that uses ultrasound to safely generate Xylitol from Sugarcane bagasse is created by
- (a) Indian Institute of Technology, Guwahati
- (b) Indian Institute of Science, Bengaluru
- (c) Indian Institute of Technology, Delhi
- (d) Indian Institute of Technology, Madras
Official APPSC answer: (a)
Solution: The answer is (A): the ultrasound-assisted fermentation process that safely turns sugarcane bagasse into xylitol was created by IIT Guwahati. Option-by-option analysis • ✅ (A) — Researchers at IIT Guwahati (team led by Prof. Arun Goyal, Department of Biosciences and Bioengineering) developed an ultrasound-assisted fermentation process to make xylitol from sugarcane bagasse. Ultrasound cavitation breaks open the lignocellulosic bagasse, releases xylose-rich sugars and speeds up fermentation, giving a safer, less energy-hungry route than the usual chemical method. This is exactly the work named in the question. • ❌ (B) — IISc Bengaluru is India's premier research institute and does pioneering biotechnology, which is why it is a tempting trap. But this particular xylitol-from-bagasse process is not its work. The question asks for the specific institute credited in the news, and that is G…